MyoKardia (MYOK) IPO Opens 10% Higher

Go back to MyoKardia (MYOK) IPO Opens 10% Higher

MyoKardia, Inc. (Nasdaq: MYOK) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO

October 29, 2015 6:01 AM EDT

ADVISORY, Oct. 29, 2015 (GLOBE NEWSWIRE) --

What: 

MyoKardia, Inc. (Nasdaq: MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).

In honor of the occasion, Tassos Gianakakos, President and Chief Executive Officer, will ring the Opening Bell. 

Where:

Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio

When:... More

MyoKardia Announces Pricing of Initial Public Offering

October 28, 2015 7:36 PM EDT

SOUTH SAN FRANCISCO--(BUSINESS WIRE)-- MyoKardia, Inc. (MyoKardia) today announced the pricing of its initial public offering of 5,437,500 shares of common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions. All of the common stock is being offered by MyoKardia. In addition, MyoKardia has granted the underwriters a 30-day option to purchase up to an additional 815,625 shares of common stock from the company at the public offering price. The company's shares are expected to begin trading on The... More